Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P06744: Variant p.Thr195Ile

Glucose-6-phosphate isomerase
Gene: GPI
Feedback?
Variant information Variant position: help 195 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Threonine (T) to Isoleucine (I) at position 195 (T195I, p.Thr195Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In HA-GPID; GPI Bari and Mola. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 195 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 558 The length of the canonical sequence.
Location on the sequence: help SSGGPRVWYVSNIDGTHIAK T LAQLNPESSLFIIASKTFTT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SSG-GPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTT

Mouse                         SKG-GPRVWFVSNIDGTHIAKTLASLSPETSLFIIASKTFT

Rat                           SKG-GPRVWFVSNIDGTHIAKTLANLNPESSLFIIASKTFT

Pig                           SAE-GPRVWFVSNIDGTHIAKTLATLNPESSLFIIASKTFT

Bovine                        SSE-GPRVWFVSNIDGTHIAKTLATLNPESSLFIIASKTFT

Rabbit                        SSG-GPRVWFVSNIDGTHIAKTLACLNPESSLFIIASKTFT

Drosophila                    GKG--LHSHFVSNIDGTHLAEVLKKVNYETTLFIVASKTFT

Slime mold                    ANDKVMRAHFVSNIDGTHLAETVKHLCPETTLFIVASKTFT

Baker's yeast                 A-G-VLDVHFVSNIDGTHIAETLKVVDPETTLFLIASKTFT

Fission yeast                 GQE-NLELHFVSNIDGTHLAEALKKCDPETTLFLIASKTFT
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 558 Glucose-6-phosphate isomerase
Modified residue 185 – 185 Phosphoserine; by CK2
Mutagenesis 185 – 185 S -> A. Retained full enzymatic activity.
Mutagenesis 185 – 185 S -> E. Decreased enzymatic activity.
Helix 189 – 196



Literature citations
Study of the molecular defects in glucose phosphate isomerase-deficient patients affected by chronic hemolytic anemia.
Baronciani L.; Zanella A.; Bianchi P.; Zappa M.; Alfinito F.; Iolascon A.; Tannoia N.; Beutler E.; Sirchia G.;
Blood 88:2306-2310(1996)
Cited for: VARIANTS HA-GPID MET-101; ILE-195; ARG-343 AND THR-525;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.